Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome
Go back to Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 42.07 -0.18 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.25 | 52 Week High | $1.35 | |||
| Open | $42.20 | 52 Week Low | $0.10 | |||
| Day High | $43.25 | P/E | N/A | |||
| Day Low | $41.56 | EPS | $0.00 | |||
| Volume | 1,778,115 | |||||
